Realta Investment Advisors Has $64,000 Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Realta Investment Advisors trimmed its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 21.3% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 900 shares of the company’s stock after selling 243 shares during the period. Realta Investment Advisors’ holdings in iShares U.S. Pharmaceuticals ETF were worth $64,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Allworth Financial LP boosted its position in iShares U.S. Pharmaceuticals ETF by 9.4% in the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after buying an additional 159 shares during the last quarter. US Bancorp DE boosted its position in iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after buying an additional 222 shares during the last quarter. Mercer Global Advisors Inc. ADV boosted its position in iShares U.S. Pharmaceuticals ETF by 7.4% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock valued at $254,000 after buying an additional 266 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.0% during the first quarter. Janney Montgomery Scott LLC now owns 12,489 shares of the company’s stock worth $848,000 after purchasing an additional 358 shares during the period. Finally, Cultivar Capital Inc. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth $25,000.

iShares U.S. Pharmaceuticals ETF Stock Down 0.2 %

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $68.92 on Friday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $56.03 and a 12 month high of $72.94. The business has a fifty day simple moving average of $71.05 and a 200 day simple moving average of $68.24. The stock has a market cap of $696.11 million, a PE ratio of 6.49 and a beta of 0.58.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.